Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay. - Northcott J; Bartha G; Harris J; Li C; Navarro FCP; Pyke RM; Hong M; Zhang Q; Ma S; Chen TX; Lai J; Udar N; et al. (Oncotarget, 2024)